Skip to content
Search

Latest Stories

ABPI welcomes new NHS research guidance for integrated care systems

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the new research guidance published by NHS England for the integrated care systems.

The guidance is said to reflect the benefits of delivering research, for patients, staff and healthcare system performance, including the economic benefits for the NHS.


Jennifer Harris, ABPI's Director of Research Policy, said: “This guidance is clear on what good research practice looks like and it’s great to see it out and available for the NHS to use.

“A research-active NHS delivers huge value to patients, staff and the system itself. We hope that putting this guidance into action will help Integrated Care Systems realize the huge benefits that research can offer, and help make the UK once again a destination of choice for developing the medical breakthroughs people need.”

The new guidance includes:

• Advice for ICSs to meet the legal requirements under the Health and Care Act, to:

o Promote and facilitate research

o Facilitate the use of research evidence (e.g. in commissioning decisions)

o Include research in their five-year plans for health and social care provision (i.e. Joint Forward Plans)

o Report on research activity to NHS England (new research metrics under development)

• An overview of research governance and the contractual requirements for delivering research, including a mandate for NHS providers to use unmodified model contracts, adhere to the interactive Costing Tool's standardized costings, and implement the National Contract Value Review process.

• A recommendation that ICSs develop a research strategy that is aligned with their 5-year plan (including for developing an ICSs' industry research portfolio) and appoint an executive lead for research. This also features advice on using health data for research and incorporating research into local workforce strategies (e.g. ensuring staff have the training and skills required to deliver research).

• Advice on how ICSs can deliver research more efficiently by reducing bureaucracy, coordinating study delivery across providers, and tailoring research to better meet local needs.

• A section dedicated to industry clinical research that reiterates the unique value provided by industry trials (e.g. early patient access to new treatments) and stresses the impact that fast study set-up timeframes and meeting recruitment target have on the UK's global competitiveness.

The ABPI have supported the development of this research mandate as part of a coalition of healthcare research organisations: the Association of Medical Research Charities (AMRC), the Academy of Medical Sciences, the Royal College of Physicians, the British Pharmacological Society, Alzheimer’s Research UK, the British Heart Foundation, the Northern Health Science Alliance, Cancer Research UK, the Medical Schools Council, the British Medical Association, the Royal College of Obstetricians and Gynaecologists, Versus Arthritis and the University of Liverpool.

More For You

Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less